TwinSeVeRS: Severity of RSV Infections in Twins

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Completed
CT.gov ID
NCT05070975
Collaborator
(none)
94
1
2.7
34.5

Study Details

Study Description

Brief Summary

Respiratory syncytial virus (RSV) infection is the most common cause of severe lower respiratory tract infection (LRTI) in the pediatric population worldwide. Age at the time of infection, prematurity, multiparity, exposure to smoke and the level of passive immunity transmitted at birth are the main risk factors for lower respiratory infection associated with RSV. Other factors, including the innate immune response, respiratory microbiota, and intra-host viral heterogeneity, may also affect outcomes but are not fully considered in RSV infection. Exploring the impact of these factors is difficult due to the heterogeneity of the population which makes statistical adjustment difficult. Thus, twin models are useful in understanding the impact of the host on the environment, as twins often share similar exposure to infection and many risk factors, but not all are ie different prenatal and postnatal conditions, differential transfer of maternal antibodies and the genetic makeup of heterozygotes.

Condition or Disease Intervention/Treatment Phase
  • Other: Epidemiology

Study Design

Study Type:
Observational
Actual Enrollment :
94 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Phenotype Severity of RSV-infections in Twins During the First Year of Life
Actual Study Start Date :
Nov 5, 2021
Actual Primary Completion Date :
Jan 27, 2022
Actual Study Completion Date :
Jan 27, 2022

Arms and Interventions

Arm Intervention/Treatment
Twins

Twins identified from the birth cohort (Hospices Civils de Lyon) with at least one twin hospitalized for an acute RSV-infection

Other: Epidemiology
Assessment of the discrepancy of clinical severity of RSV-infections between twin infants.

Outcome Measures

Primary Outcome Measures

  1. Percentage of discordant twin pairs in severity of Respiratory Syncytial Virus infections. [1 day]

    The primary outcome measure is the percentage of discordant twin pairs of at least one severity level on the WHO (World Health Organization) scale. The discrepancy in the level of severity is obtained by retrospective analysis of the data from the medical file.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 354 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Twins born at Hospices Civils de Lyon in the years 2012 to 2020

  • At least one twin hospitalized with positive RSV-PCR during the first year of life

Exclusion Criteria:
  • Major differential underlying disease between twins

  • Death of a twin before the RSV epidemic period of the first year of life

  • Nosocomial infection

  • Lack of understanding of the study or questionnaire by parents

  • Lack of parental consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Femme-Mère-Enfant des Hospices Civils de Lyon Bron France 69677

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT05070975
Other Study ID Numbers:
  • 69HCL21_0634
First Posted:
Oct 7, 2021
Last Update Posted:
Jul 6, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022